[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@AbbVieUSOncMed AbbVie Oncology Medical Affairs
AbbVie Oncology Medical Affairs posts on X about $abbv, rr, poster the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Month XXX +116%
- X Months XXXXX -XX%
- X Year XXXXX -XX%
Mentions: XX #
Followers: XXX #
- X Month XXX +2.90%
- X Months XXX +16%
- X Year XXX +55%
CreatorRank: undefined #
Social Influence
Social category influence stocks XXX%
Social topic influence $abbv #28, rr #52, poster XXXX%
Top accounts mentioned or mentioned by @abbvie @ashhematology @cthieblemont @iaslc @rakv2000 @lorilesliemd @joshuabrodymd @abpau @anetoc @anitiju0312 @pavlovskymig @rajshekharucms @yhkarimi @chanyooncheah @drjulievose
Top assets mentioned AbbVie Inc (ABBV)
Top Social Posts
Top posts by engagements in the last XX hours
"See updated @Abbvie data in #NSCLC at #NACLC2025 poster session held by @IASLC on Saturday December 6th 2025 #LungCancer #LCSM #NSCLC Abstract PP01.37 Post-hoc analysis of treatment-related adverse reactions with an ADC in NSCLC See abstracts here:"
X Link 2025-12-04T21:24Z XXX followers, XXX engagements
"Join us to see updated @AbbVie data in #DLBCL at #ASH2025 @ASH_hematology #lymsm #lymphoma #hematology Abstract 1959: Outpatient administration in R/R DLBCL by Dr. Adelba Torres @rakv2000 et al. Abstract 1955: 3-year follow-up in 1L DLBCL by Dr. Lorenzo Falchi et al"
X Link 2025-12-05T19:21Z XXX followers, XXX engagements
"Here at @AbbVie we remain committed to advancing oncology research and are proud to share XX abstracts including X oral presentations and XX posters across multiple disease states at #ASH25. Visit AbbVies booth # XXX and find our abstracts here:"
X Link 2025-12-06T12:00Z XXX followers, XX engagements
"Join us for new and updated @AbbVie #FL data at #ASH2025 Oral 465: 3-year follow-up in 1L FL @LoriLeslieMD @JoshuaBrodyMD @ab_pau et al. Oral 466: First Disclosure of Phase X results in R/R FL by Dr Lorenzo Falchi @anetoc @anitiju0312 @c_thieblemont @Pavlovsky_Mig et al"
X Link 2025-12-06T19:06Z XXX followers, XXX engagements
"Join us at #ASH25 as @AbbVie presents multiple scientific updates in #MultipleMyeloma research and development"
X Link 2025-12-06T21:06Z XXX followers, XX engagements
"Join @AbbVie during #ASH2025 for a poster on the real-world treatment landscape and outcomes of patients with BPDCN. #leusm #BPDCN Read more:"
X Link 2025-12-07T14:55Z XXX followers, XXX engagements
"At #ASH25 results are presented by Dr. Raj Chakraborty @rajshekharucms on phase 1/2 dose escalation and expansion of B-Cell Maturation Antigen x CD3 Bispecific Antibody in patients with relapsed or refractory light chain amyloidosis"
X Link 2025-12-07T20:45Z XXX followers, XXX engagements
"Join us and listen in on @AbbVie data at #ASH2025 @ASH_hematology #lymsm #leukemia #hematology Oral 1015: CD3xCD20 bispecific antibody-based regimens in pts with RT by Dr. Philip Thompson et al. Oral 1017: 2-year follow-up in pts with RT by Dr. Arnon Kater et al"
X Link 2025-12-07T21:47Z XXX followers, XX engagements
"Join us to see updated @AbbVie data in #DLBCL at #ASH2025 @ASH_hematology #lymsm #lymphoma #hematology Abstract 5513: 4-year follow-up in R/R LBCL by @Yhkarimi @chanyooncheah @DrJulieVose et al. You can find this scientific abstract here:"
X Link 2025-12-07T21:49Z XXX followers, XXX engagements
"Join us to see new @AbbVie PRO data in #FL at #ASH2025 @ASH_hematology #lymsm #lymphoma #hematology #FollicularLymphoma Abstract 5370: HRQoL in pts with R/R FL by Prof Kim Linton @c_thieblemont et al. You can find this scientific abstract here:"
X Link 2025-12-07T21:50Z XXX followers, XXX engagements
"Join us at #ASH25 as @AbbVie presents scientific updates in #MultipleMyeloma research and development. Abstracts can be found at the #ASH25 abstract site:"
X Link 2025-12-08T22:00Z XXX followers, XX engagements